Malignant melanoma of the conjunctiva

Cancer Control

Volumn 11, Issue 5, 2004, Pages 310-316

  Brownstein, Seymour ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; MITOMYCIN C; RUTHENIUM; STRONTIUM;

ALCOHOL CORNEAL EPITHELIALECTOMY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONJUNCTIVA TUMOR; CORNEA SURGERY; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; EVISCERATION; HISTOPATHOLOGY; HUMAN; INTRAOCULAR TUMOR; MEDLINE; MELANOMA; MELANOSIS; METASTASIS; NONHUMAN; ORBIT TUMOR; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 14644395462     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100505     Document Type: Review

References (57)

1. Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42:321-350.
2. Jakobiec FA. Conjunctival melanoma. Arch Ophthalmol. 1980;98:1378-1384.
3. Yu GP, Hu DN, McCormick S, et al. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135:800-806.
4. Tuomaala S, Kivela T. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;136:1189-1190.
5. Paridaens AD, Minassian DC, McCartney AC, et al. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994;78:252-259.
6. McDonnell JM, Carpenter JD, Jacobs P, et al. Conjunctival melanocytic lesions in children. Ophthalmology. 1989;96:986-993.
7. Stratus BA. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;136:1190.
8. Jakobiec FA, Rini FJ, Fraunfelder FT, et al. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma: experience with 62 cases. Ophthalmology. 1988;95:1058-1070.
9. Folberg R, Jakobiec FA, Bernardino VB, et al. Benign conjunctival melanocytic lesions: clinicopathologic features. Ophthalmology. 1989;96:436461.
10. Shields CL, Fasiudden A, Mashayekhi A, et al. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol. 2004;122:167-175.
11. Zimmerman LE. Criteria for management of melanosis. Arch Ophthalmol. 1966;76:307-308.
12. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96:147-166.
13. Folberg R. Melanocytic lesions of the conjunctiva. In: Spencer WH. Ophthalmic Pathology: An Atlas and Textbook. 4th ed. Philadelphia, Pa: WB Saunders Co; 1996.
14. Brownstein S, Henry M, Bernardo AI. Malignant melanoma of the conjunctiva after 11 years. Can J Ophthalmol. 1979;14:142-146.
15. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985;16:129-135.
16. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol. 1985;16:136-143.
17. Brownstein S, Jakobiec FA, Wilkinson RD, et al. Cryotherapy for precancerous melanosis (atypical melanocytic hyperplasia) of the conjunctiva. Arch Ophthalmol. 1981;99:1224-1231.
18. Jakobiec FA, Brownstein S, Wilkinson RD, et al. Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol. 1980;98:1390-1396.
19. Ackerman AB, Sood R, Koenig M. Primary acquired melanosis of the conjunctiva is melanoma in situ. Mod Pathol. 1991;4:253-263.
20. Folberg R, Jakobiec FA, McLean IW, et al. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ? Mod Pathol. 1992;5:2-5.
21. Ackerman AB. Ideas in pathology: response to Dr. Folberg et al. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ? Mod Pathol. 1992;5:6-8.
22. Finger FT, Yu GP. Conjunctival melanoma: is it increasing in the United States?. Am J Ophthalmol. 2003;136:1190-1191.
23. Gloor P, Alexandrakis G. Clinical characterization of primary acquired melanosis. Invest Ophthalmol Vis Sci. 1995;36:1721-1729.
24. Paridaens AD, McCartney AC, Hungerford JL. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol. 1992;76:163-165.
25. Tuomaala S, Aine E, Saari KM, et al. Corneally displaced malignant conjunctival melanomas. Ophthalmology. 2002;109;914-919.
26. Esmaeli B, Wang X, Youssef A, et al. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology. 2001;108:2101-2105.
27. Tuomaala S, Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology. 2004;111:816-821.
28. Cook BE Jr, Lucarelli MJ, Lemke BN, et al. Eyelid lymphatics II: a search for drainage patterns in the monkey and correlations with human lymphatics. Ophthal Plast Reconstr Surg. 2002;18:99-106.
29. Gausas RE, Gonnering RS, Lemke BN, et al. Identification of human orbital lymphatics. Ophthal Plast Reconstr Surg. 1999;15:252-259.
30. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors: the 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997;115:808-815.
31. Shields JA, Shields CL, De Potter P. Surgical Management of circumscribed conjunctival melanomas. Ophthal Plast Reconstr Surg. 1998;14:208-215.
32. Grossniklaus HE, Margo CE, Solomon AR. Indeterminate melanocytic proliferations of the conjunctiva. Arch Ophthalmol. 1999;117:1131-1136.
33. Margo CE, Roper DL, Hidayat AA. Borderline melanocytic tumor of the conjunctiva: diagnostic and therapeutic considerations. J Pediatr Ophthalmol Strabismus. 1991;28:268-270.
34. Dorey MW, Brownstein S, Faraji H, et al. Immunohistochemical profile and histochemical analysis of primary acquired melanosid of the conjuctiva. Invest Ophthalmol Vis Sci. 2003;44:E-Abstract 2427.
35. Gonder JR, Shields JA, Albert DM, et al. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology. 1982;89:953-960.
36. Teekhasaenee C, Ritch R, Rutnin U, et al. Glaucoma in oculodermal melanocytosis. Ophthalmology. 1990;97:562-570.
37. Paridaens AD, McCartney AC, Minassian DC, et al. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol. 1994;78:520-528.
38. Stannard CE, Sealy GRH, Hering ER, et al. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology. 2000;107:951-958.
39. Jakobiec FA, Brownstein S, Wilkinson RD, et al. Adjuvant cryotherapy for focal nodular melanoma of the conjunctiva. Arch Ophthalmol. 1982;100:115-118.
40. Jakobiec FA, Brownstein S, Albert W, et al. The role of cryotherapy in the management of conjunctival melanoma. Ophthalmology. 1982;89:502-515.
41. Codere F, Brownstein S, Garwood JL, et al. Carbon dioxide laser treatment of the conjunctiva and the cornea. Ophthalmology. 1988;95:37-45.
42. Lommatzsch PK, Lommatzsch RE, Kirsch I, et al. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990;74:615-619.
43. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol. 2002;25:248-255.
44. Frucht-Pery J, Pe'er J. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol. 1996;114:1261-1264.
45. Yuen VH, Jordan DR, Brownstein S, et al. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva. Ophthalmic Plast Reconstr Surg. 2003;19:149-151.
46. Rodriguez-Ares T, Tourino R, De Rojas V, et al. Topical mitomycin C in the treatment of pigmented conjunctival lesions. Cornea. 2003;22:114-117.
47. Shields CL, Shields JA, Armstrong T. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am J Ophthalmol. 2001;132:576-578.
48. Amato M, Esmaeli B, Ahmadi MA, et al. Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies. Ophthal Plast Reconstr Surg. 2003;19:102-106.
49. Esmaeli B, Reifler D, Prieto VG, et al. Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol. 2003;121:1779-1783.
50. Baroody M, Holds JB, Kokoska MS, et al. Conjunctival melanoma metastasis diagnosed by sentinel lymph node biopsy. Am J Ophthalmol. 2004;137:1147-1149.
51. Bataille V, Pinney E, Hungerford JL, et al. Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol. 1993;129:198-201.
52. Richtig E, Langmann G, Mullner K, et al. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Ophthalmologica. 2004;218:111-114.
53. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:1497-1507.
54. Shields CL. Conjunctival melanoma. Br J Ophthalmol. 2002;86:127.
55. Anastassiou G, Heiligenhaus A, Bechrakis N, et al. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol. 2002;86:163-167.
56. Tuomaala S, Eskelin S, Tarkkanen A, et al. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43:3399-3408.
57. Fuchs U, Kivela T, Liesto K, et al. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer. 1989;59:261-267.